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Introduction

Progestagen-associated endometrial protein (PAEP, pregnancyassociated endometrial ␣2 globulin, placental protein 14 and glycodelin) is a 28-kD glycoprotein of the lipocalin superfamily. This protein is synthesized by cells of the human reproductive tract, especially the secretory endometrium and deciduas of early pregnancy. Others have found a remarkably high PAEP concentration within amniotic fluid during the first half of pregnancy
. PAEP has also been identified within cells of the megakaryocytic lineage, including platelets [3] . Lastly, PAEP has been previously suggested to contribute to the maternal immunotolerance involved in embryogenesis and human foetal development [4] [5] [6] [7] [8] . Although the definitive role of PAEP in malignancy is relatively unknown, it is well described as having a negative influence upon the human immune system, with an overall immunosuppressive effect.
Recently, it has been shown that PAEP is frequently expressed in tumours derived from various reproductive organs and gynecologic malignancies, such as endometrial, ovarian, breast and cervical cancers [9] [10] [11] [12] . However, we still know relatively little about the true function and role of PAEP gene expression in tumourigenesis and tumour progression. The utilization of histone deacetylase inhibitors (HDACI) has been shown to stimulate cell migration in human endometrial adenocarcinoma via the up-regulation and overexpression of PAEP [13] . Song et al. revealed [14] . Here, we show that PAEP highly expresses in both thick primary and metastatic melanoma tissues and daughter cells, subsequently promoting tumour growth in human melanoma.
Melanomagenesis is a result of the malignant transformation of neural crest-derived melanocytes [15] . It is one of the most aggressive forms of human cancer and is responsible for 6/7 skin cancer-related deaths, with only rare long-term survivors once metastatic disease has developed [16] . Thus 
Materials and methods
Tumour specimens and cell lines
Real-time quantitative RT-PCR (qRT-PCR)
Mass spectrometry
The analysis of the secreted proteome was conducted as previously described [20, 21] 
Matrigel invasion assay
The lower chambers of the 24- 
Human melanoma xenograft model in athymic mice
We utilized a murine model with human melanoma xenografts as previously described [22] (Fig. 1C) .
We (Fig. 1D) Figure 1E . Since glycosylation prevents mass spectrometry sequencing, we did not detect the sequence 79-93 due to the glycosylated Asn81 [25, 26] . However, we still detected a weak peak for the sequence 33-58 although it is reported to be glycosylated at Asn46 [25, 26] , indicating a small amount of unglycosylated peptide was present. The sequence 102-142 contains a predicted glycosylation site [27] reported not to be occupied [25, 26] ; however, the peptide was too big to be sequenced (4.7 kD (Fig. 2B) . Fig. 2C right) . Fig. 4A and B) . To monitor whether the shRNA constructs were possibly exerting effects upon the activation of interferon and downstream effectors [30, 31] , expression of Phospho-eIF2␣ (P-eIF2-␣) was also examined. We did not observe any significant differences in gene expression for P-elF2-␣ (Fig. 4B) . Thus (Fig. 5A) (Fig. 5B) . In 624.38-Mel cells, the mice in all five groups developed tumours. However, similar to the MCC69B groups, the tumour growth of three shPAEPs clones was significantly decreased by 33% compared to empty vector and shControl cells (P Ͻ 0.01, DUNNETT t-test, Fig. 5C ). To further confirm the specificity of shPAEP knockdown, we also applied a shPAEP2 clone derived from MCC69B cells, which reduced PAEP 
Therefore, we utilized the siPAEP10-12 pool to silence PAEP expression in MCC69B and 624.38-Mel cells. This was followed by culturing the melanoma cells in soft agar to examine whether the inhibition of PAEP gene expression affected cell colony formation. This revealed a significant decrease in melanoma cell colony formation in the two cell lines (Fig. 2C left). Subsequent analysis of each cell line with a colorimetric MTT assay revealed significant decreases of 46% and 27%, respectively, in total cell numbers in PAEP siRNA-treated MCC69B and 624.38-Mel samples (P Ͻ 0.05,
Silencing of PAEP gene expression decreases the migration and invasion of melanoma cells
Discussion
Melanoma is one of the most aggressive cancers in human beings, and despite immense efforts to understand its relative ease in its ability to metastasize, our knowledge remains limited as to the molecular and genetic changes that are involved in this process. One early hypothesis is the Clark model of melanoma progression, which describes a five-step sequence of events, beginning with a benign nevus transforming through a series of histological stages, eventually developing into a melanoma cell
with subsequent metastatic capacity [16] PAEP is a secreted glycoprotein, which was first isolated from the human placenta, amniotic fluid, pregnancy deciduas and seminal plasma [1] . The protein has been suggested to contribute to the maternal immunotolerance in embryogenesis by suppressing the activity of immune effector cells [4] [5] [6] [7] and contraception by inhibiting the interactions between sperm and the zona pellucida [8] regulating sperm function [35] . In accordance with its physiological functions, PAEP is reported to be frequently expressed in gynecologic malignancies [9] [10] [11] [12] . However, the true function and role of PAEP gene expression in tumourigenesis and tumour progression remain unclear.
Recently, PAEP was observed to stimulate tumour cell migration induced by HDACI in human endometrial adenocarcinoma [13] and to promote neovascularization mediated by VEGF [14] . Contrary to these results, several studies have suggested that PAEP expression is associated with differentiated epithelia and its expression induces cell differentiation, thereby reducing the malignant characteristics of cancer cells [10, 35] 
